Omniab Inc Stock Alpha and Beta Analysis

OABI Stock  USD 3.21  0.03  0.94%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as OmniAb Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in OmniAb over a specified time horizon. Remember, high OmniAb's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to OmniAb's market risk premium analysis include:
Beta
0.85
Alpha
(0.31)
Risk
2.98
Sharpe Ratio
(0.11)
Expected Return
(0.32)
Please note that although OmniAb alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, OmniAb did 0.31  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of OmniAb Inc stock's relative risk over its benchmark. OmniAb Inc has a beta of 0.85  . As returns on the market increase, OmniAb's returns are expected to increase less than the market. However, during the bear market, the loss of holding OmniAb is expected to be smaller as well. As of now, OmniAb's Tangible Book Value Per Share is increasing as compared to previous years. The OmniAb's current Price Book Value Ratio is estimated to increase to 3.58, while Book Value Per Share is projected to decrease to 2.23.

Enterprise Value

899.5 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out OmniAb Backtesting, OmniAb Valuation, OmniAb Correlation, OmniAb Hype Analysis, OmniAb Volatility, OmniAb History and analyze OmniAb Performance.

OmniAb Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. OmniAb market risk premium is the additional return an investor will receive from holding OmniAb long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in OmniAb. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate OmniAb's performance over market.
α-0.31   β0.85

OmniAb expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of OmniAb's Buy-and-hold return. Our buy-and-hold chart shows how OmniAb performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

OmniAb Market Price Analysis

Market price analysis indicators help investors to evaluate how OmniAb stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading OmniAb shares will generate the highest return on investment. By understating and applying OmniAb stock market price indicators, traders can identify OmniAb position entry and exit signals to maximize returns.

OmniAb Return and Market Media

The median price of OmniAb for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 is 3.9 with a coefficient of variation of 8.69. The daily time series for the period is distributed with a sample standard deviation of 0.34, arithmetic mean of 3.86, and mean deviation of 0.26. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Love Steven of 13333 shares of OmniAb subject to Rule 16b-3
11/01/2024
2
Aurinia Pharmaceuticals Q3 Earnings and Revenues Beat Estimates
11/07/2024
3
OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights - StockTitan
11/12/2024
4
OmniAb Announces Earnings Results
11/14/2024
5
Janus Henderson Group PLCs Strategic Acquisition in OmniAb Inc
11/15/2024
6
Disposition of 31074 shares by Matthew Foehr of OmniAb at 3.68 subject to Rule 16b-3
11/25/2024
7
Disposition of 23871 shares by Kurt Gustafson of OmniAb at 4.13 subject to Rule 16b-3
12/09/2024
8
OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering Therapeutics Conference
12/16/2024
9
Why OmniAb, Inc. Is One of the Best Biotech Penny Stocks to Invest in Now
12/30/2024

About OmniAb Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including OmniAb or other stocks. Alpha measures the amount that position in OmniAb Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 2025 (projected)
Days Sales Outstanding187.1441.0747.2344.87
PTB Ratio0.91.962.253.58

OmniAb Upcoming Company Events

As portrayed in its financial statements, the presentation of OmniAb's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, OmniAb's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of OmniAb's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of OmniAb. Please utilize our Beneish M Score to check the likelihood of OmniAb's management manipulating its earnings.
4th of April 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with OmniAb

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether OmniAb Inc is a strong investment it is important to analyze OmniAb's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact OmniAb's future performance. For an informed investment choice regarding OmniAb Stock, refer to the following important reports:
OmniAb technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of OmniAb technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of OmniAb trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...